Bacterial vaginosis secondary prevention

Sexually transmitted diseases Main Page
Vaginitis Main Page
Bacterial vaginosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Bacterial vaginosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Amsel Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bacterial vaginosis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bacterial vaginosis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bacterial vaginosis secondary prevention
CDC on Bacterial vaginosis secondary prevention
Bacterial vaginosis secondary prevention in the news
Blogs on Bacterial vaginosis secondary prevention
Directions to Hospitals Treating Bacterial vaginosis
Risk calculators and risk factors for Bacterial vaginosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Effective measure for the secondary prevention of infective conjunctivitis include maintaining vaginal pH at 4.5, bacteriotherapy, avoid douching and change in the method of contraception.

Secondary prevention

Effective measure for the secondary prevention of infective conjunctivitis include:

• Maintaining vaginal pH at 4.5
  • Use intravaginal lactate gel
  • Bacteriotherapy
    • Intravaginal and oral administration of lactobacilli
• Stop douching
• Changing the method of contraception